Difference between revisions of "WSI21-60-Case-4"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 32: Line 32:
 
|subject=Z0FBQUFBQmdZUGhNbWlueHp5VmlBeEVGXy1yS3NubHQ1X2N3VDgzenNhaGd1QVA4a25ZMUdFRjYyNmJXbkVrak1tUU81cEMzQTZ1Sm55SUw5XzQ0UklWSXBnRHhKUWFxUHc9PQ
 
|subject=Z0FBQUFBQmdZUGhNbWlueHp5VmlBeEVGXy1yS3NubHQ1X2N3VDgzenNhaGd1QVA4a25ZMUdFRjYyNmJXbkVrak1tUU81cEMzQTZ1Sm55SUw5XzQ0UklWSXBnRHhKUWFxUHc9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Em99
 +
|authoredOn=March 28, 2021 09:42:21 PM
 
}}
 
}}

Latest revision as of 14:16, December 9, 2024

WSI21-60-Case-4
Pancreatic cyst
Satisfactory for evaluation

Neoplastic: Other Neoplastic mucinous cyst with intermediate-grade atypia. See note. Note: The mucinous etiology is established by the presence of extracellular

mucin and elevated CEA (>192 ng/ml). The epithelium is atypical and represents at least intermediate-grade dysplasia.
April 7, 2021 12:00:00 AM